A
AbCellera Biologics Inc. (ABCL)
NMS – Real Time Price. Currency in USD
3.27
-0.08 (-2.39%)
At close: Mar 27, 2026, 4:00 PM EDT
3.26
-0.01 (-0.31%)
After-hours: Mar 27, 2026, 7:34 PM EDT
Get all premium features to the best stock analysis tool
NMS – Real Time Price. Currency in USD
3.27
-0.08 (-2.39%)
At close: Mar 27, 2026, 4:00 PM EDT
3.26
-0.01 (-0.31%)
After-hours: Mar 27, 2026, 7:34 PM EDT
This stock has a consensus price target of $14.71 based on the ratings of 8 analysts. The high is $28.00 and the low is $4.00.
| Target | Lowest Price Target | Consensus Price Target | Highest Price Target |
|---|---|---|---|
| Price | $ 4 | $ 14.71 | $ 28 |
| Change | 22.32% | 349.85% | 756.27% |
| Date | Upside/Downside | Analyst Firm | Price Target | Rating Change | Rating |
|---|---|---|---|---|---|
| 2025-11-07 | 22.32% | Leerink Partners | $4 | Downgrades | Outperform → Market Perform |
| 2025-08-08 | 114.07% | Stifel | $8 → $7 | Maintains | Buy |
| 2025-07-14 | 205.81% | Keybanc | $5 → $10 | Maintains | Overweight |
| 2025-07-07 | 52.91% | Leerink Partners | $5 | Assumes | Outperform |
| 2025-05-16 | 205.81% | Truist Securities | $28 → $10 | Maintains | Buy |